A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (301)
Public ClinicalTrials.gov record NCT03168321. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2 Arm, Parallel Group Study Comparing the Safety and Efficacy of IDP-123 Lotion and IDP-123 Vehicle Lotion in the Treatment of Acne Vulgaris
Study identification
- NCT ID
- NCT03168321
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Bausch Health Americas, Inc.
- Industry
- Enrollment
- 813 participants
Conditions and interventions
Conditions
Interventions
- IDP-123 Lotion Drug
- IDP-123 Vehicle Lotion Drug
Drug
Eligibility (public fields only)
- Age range
- 9 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 28, 2017
- Primary completion
- Jun 6, 2018
- Completion
- Jun 6, 2018
- Last update posted
- Mar 31, 2021
2017 – 2018
United States locations
- U.S. sites
- 42
- U.S. states
- 23
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Valeant Site 19 | Phoenix | Arizona | 85032 | — |
| Valeant Site 21 | Phoenix | Arizona | 85032 | — |
| Valeant Site 24 | Hot Springs | Arkansas | 71913 | — |
| Valeant Site 04 | La Mesa | California | 91942 | — |
| Valeant Site 02 | Manhattan Beach | California | 90266 | — |
| Valeant Site 42 | Murrieta | California | 92562 | — |
| Valeant Site 39 | Sacramento | California | 95819 | — |
| Valeant Site 01 | San Diego | California | 22434 | — |
| Valeant Site 37 | Wheat Ridge | Colorado | 80033 | — |
| Valeant Site 35 | Boca Raton | Florida | 33486 | — |
| Valeant Site 40 | North Miami Beach | Florida | 33162 | — |
| Valeant Site 33 | Ormond Beach | Florida | 32174 | — |
| Valeant Site 27 | Pembroke Pines | Florida | 33028 | — |
| Valeant Site 13 | Sanford | Florida | 32771 | — |
| Valeant Site 03 | West Palm Beach | Florida | 33401 | — |
| Valeant Site 26 | Newnan | Georgia | 30263 | — |
| Valeant Site 30 | Boise | Idaho | 83704 | — |
| Valeant Site 06 | Arlington Heights | Illinois | 60005 | — |
| Valeant Site 23 | New Albany | Indiana | 47150 | — |
| Valeant Site 17 | South Bend | Indiana | 46617 | — |
| Valeant Site 31 | Overland Park | Kansas | 66215 | — |
| Valeant Site 22 | Louisville | Kentucky | 40217 | — |
| Valeant Site 08 | Metairie | Louisiana | 70006 | — |
| Valeant Site 38 | Detroit | Michigan | 48202 | — |
| Valeant Site 16 | Warren | Michigan | 48088 | — |
| Valeant site 20 | New York | New York | 10022 | — |
| Valeant Site 36 | New York | New York | 10075 | — |
| Valeant Site 09 | High Point | North Carolina | 27262 | — |
| Valeant Site 32 | Cincinnati | Ohio | 45236 | — |
| Valeant Site 11 | Dublin | Ohio | 43016 | — |
| valeant Site 07 | Gresham | Oregon | 97030 | — |
| Valeant Site 15 | Johnston | Rhode Island | 02919 | — |
| Valeant Site 34 | Knoxville | Tennessee | 37917 | — |
| valeant Site 14 | Nashville | Tennessee | 37215 | — |
| Valeant Site 12 | Austin | Texas | 78759 | — |
| Valeant Site 05 | Katy | Texas | 77494 | — |
| Valeant Site 18 | Plano | Texas | 75093 | — |
| Valeant Site 25 | San Antonio | Texas | 78213 | — |
| Valeant Site 43 | Webster | Texas | 77598 | — |
| Valeant Site 41 | Salt Lake City | Utah | 84114 | — |
| Valeant Site 45 | Norfolk | Virginia | 23507 | — |
| Valeant Site 44 | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03168321, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 31, 2021 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03168321 live on ClinicalTrials.gov.